Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 281, Issue 6, Pages H2480-H2489Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.2001.281.6.H2480
Keywords
potassium channel; activation; inactivation; protein kinase A; protein kinase C
Ask authors/readers for more resources
The vasoconstrictor angiotensin II (ANG II) inhibits several types of K+ channels. We examined the inhibitory mechanism of ANG II on voltage-gated K+ (K-V) currents (I-K V) recorded from isolated rat arterial smooth muscle using patch-clamp techniques. Application of 100 nM ANG II accelerated the activation of I-K V but also caused inactivation. These effects were abolished by the AT(1) receptor antagonist losartan. The protein kinase A (PKA) inhibitor Rp-cyclic 3',5'-hydrogen phosphothioate adenosine (100 muM) and an analog of diacylglycerol, 1,2-dioctanyoyl-rac-glycerol (2 muM), caused a significant reduction of I-K V. Furthermore, the combination of 5 muM PKA inhibitor peptide 5-24 (PKA-IP) and 100 muM protein kinase C (PKC) inhibitor peptide 19-27 (PKC-IP) prevented the inhibition by ANG II, although neither alone was effective. The ANG II effect seen in the presence of PKA-IP remained during addition of the Ca2+-dependent PKC inhibitor Go6976 (1 muM) but was abolished in the presence of 40 muM PKC-epsilon translocation inhibitor peptide. These results demonstrate that ANG II inhibits K-V channels through both activation of PKC-epsilon and inhibition of PKA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available